Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€31.44

€31.44

0.960%
0.3
0.960%
€59.00
 
17:05 / Tradegate WKN: A3ENQ5 / Name: Schott Pharma & Co. Kgaa / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Schott Pharma AG & Co. Kgaa Stock

Schott Pharma AG & Co. Kgaa gained 0.960% compared to yesterday.
The community is currently still undecided about Schott Pharma AG & Co. Kgaa with 2 Buy predictions and 0 Sell predictions.
With a target price of 59 € there is a hugely positive potential of 87.66% for Schott Pharma AG & Co. Kgaa compared to the current price of 31.44 €.

Pros and Cons of Schott Pharma AG & Co. Kgaa in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: Promotion for SCHOTT Pharma: Listed on the MDAX for the first time
EQS-News: Promotion for SCHOTT Pharma: Listed on the MDAX for the first time
EQS-News: Promotion for SCHOTT Pharma: Listed on the MDAX for the first time
EQS-News: SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance 
EQS-News: SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance 
EQS-News: SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance 
EQS-News:  SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement
EQS-News:  SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement
EQS-News:  SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement